Are patients recovering from Kawasaki disease at increased risk for accelerated atherosclerosis? A meta-analysis

Yuan-Yuan Zeng1, Feng Chen1, Yong Zhang1

  • 1Department of Pharmacy, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing 210008, China.

Insights

Patients with a history of Kawasaki disease (KD) show signs of endothelial dysfunction and inflammation, increasing their risk for atherosclerosis. This meta-analysis confirms KD as a potential risk factor for accelerated atherosclerosis development.

Area of Science:

  • Cardiovascular Research
  • Pediatric Cardiology
  • Inflammatory Diseases

Background:

  • Kawasaki disease (KD) is linked to potential endothelial dysfunction and atherosclerosis.
  • A clear consensus on the KD-atherosclerosis relationship is lacking.
  • This study investigates KD history and accelerated atherosclerosis risk.

Purpose of the Study:

  • To determine if patients with a history of Kawasaki disease (KD) face an increased risk of accelerated atherosclerosis.
  • To synthesize existing evidence through a meta-analysis.

Main Methods:

  • Systematic literature search of PubMed, Embase, and SpringerLink databases.
  • Inclusion of studies focusing on atherosclerosis risk factors.
  • Meta-analysis of case-control studies using RevMan 5.3 software.

Main Results:

  • Analysis of 20 studies with 1684 participants (990 KD patients, 694 controls).
  • Significantly higher carotid intima-media thickness (cIMT) and hsCRP levels in KD patients.
  • Significantly lower flow-mediated dilatation (FMD) in KD patients, indicating endothelial dysfunction.

Conclusions:

  • Patients with a history of KD exhibit endothelial dysfunction and inflammation.
  • These factors are identified as significant risk factors for atherosclerosis development.
  • KD history may predispose individuals to accelerated atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
67
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
185
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
98
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
88
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
90